Clinical Trial Update: Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oxaliplatin/5-FU/leucovorin with versus without vatalanib in metastatic colorectal cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Neoplasms
• Colorectal Neoplasms
• Rectal Neoplasms

Drugs mentioned

• Oxaliplatin/5-FU/Leucovorin
• Vatalanib (vatalanib)

Snippet

Sponsor: Novartis | Conditions: Colorectal Neoplasms, Colonic Neoplasms | Phase 3 | Status: COMPLETED